Galanin is up-regulated in colon adenocarcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 11, 2007, Pages 2373-2378

  Kye, Young Kim ^a   Kee, Mee K ^a   Seon, Ah Chong ^b,c   Myeong, Jin Nam ^b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Gachon University College of Medicine   (South Korea)

^c HanCell Inc   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GALANIN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; COLON ADENOCARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; UPREGULATION;

ADENOCARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; FEMALE; GALANIN; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 38849109277     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0740     Document Type: Article

References (25)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Berger A, Santic R, Hauser-Kronberger C, et al. Galanin and galanin receptors in human cancers. Neuropeptides 2005;39:353-9.
3. Inger DB. Colorectal cancer screening. Prim Care 1999;26:179-87.
4. Tatemoto K, Rokaeus A, Jornvall H, McDonald TJ, Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 1983;164:124-8.
5. Schmidt WE, Kratzin H, Eckart K, et al. Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropeptide. Proc Natl Acad Sci U S A 1991;88:11435-9.
6. Kask K, Langel U, Bartfai T. Galanin - a neuropeptide with inhibitory actions. Cell Mol Neurobiol 1995;15:653-73.
7. Floren A, Land T, Langel U. Galanin receptor subtypes and ligand binding. Neuropeptides 2000;34:331-7.
8. Perel Y, Amrein L, Dobremez E, Rivel J, Daniel JY, Landry M. Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status. Br J Cancer 2002;86:117-22.
9. Xia CY, Yuan CX, Yuan CG. Galanin inhibits the proliferation of glial olfactory ensheathing cells. Neuropeptides 2005;39:453-9.
10. El-Salhy M. Effects of octreotide, galanin and serotonin on a human gastric cancer cell line. Oncol Rep 2005;13:787-91.
11. Henson BS, Neubig RR, Jang I, et al. Galanin receptor 1 has anti-proliferative effects in oral squamous cell carcinoma. J Biol Chem 2005;280:22564-71.
12. El-Salhy M, Starefeldt A. Direct effects of octreotide, galanin and serotonin on human colon cancer cells. Oncol Rep 2003;10:1723-8.
13. Iishi H, Tatsuta M, Baba M, et al. Inhibition by galanin of experimental carcinogenesis induced by azaserine in rat pancreas. Int J Cancer 1998;75:396-9.
14. Skotheim RI, Lind GE, Monni O, et al. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 2005;65:5588-98.
15. Hammond PJ, Smith DM, Akinsanya KO, Mufti WA, Wynick D, Bloom SR. Signalling pathways mediating secretory and mitogenic responses to galanin and pituitary adenylate cyclase-activating polypeptide in the 235-1 clonal rat lactotroph cell line. J Neuroendocrinol 1996;8:457-64.
16. 2+ mobilization, inositol phosphate accumulation, and clonal growth in small cell lung cancer cells. Cancer Res 1991;51:1674-9.
17. Seufferlein T, Rozengurt E. Galanin, neurotensin, and phorbol esters rapidly stimulate activation of mitogen-activated protein kinase in small cell lung cancer cells. Cancer Res 1996;56:5758-64.
18. Berling B, Kolbinger F, Grunert F, et al. Cloning of a carcinoembryonic antigen gene family member expressed in leukocytes of chronic myeloid leukemia patients and bone marrow. Cancer Res 1990;50:6534-9.
19. Thompson JA, Grunert F, Zimmermann W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 1991;5:344-66.
20. Scholzel S, Zimmermann W, Schwarzkopf G, Grunert F, Rogaczewski B, Thompson J. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol 2000;156:595-605.
21. Berglund A, Molin D, Larsson A, Einarsson R, Glimelius B. Tumour markers as early predictors of response to chemotherapy in advanced colorectal carcinoma. Ann Oncol 2002;13:1430-7.
22. Carpelan-Holmstrom M, Haglund C, Kuusela P, Jarvinen H, Roberts PJ. Preoperative serum levels of CEA and CA 242 in colorectal cancer. Br J Cancer 1995;71:868-72.
23. Carpelan-Holmstrom M, Haglund C, Lundin J, Jarvinen H, Roberts P. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer. Eur J Cancer 1996;32A:1156-61.
24. Carpelan-Holmstrom MA, Haglund CH, Jarvinen HJ, Roberts PJ. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer. Anticancer Res 1996;16:981-6.
25. Carpelan-Holmstrom MA, Haglund CH, Roberts PJ. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen. Dis Colon Rectum 1996;39:799-805.